JUNE 24, 2016 – BY BRAD PERRIELLO   InVivo Therapeutics (NSDQ:NVIV) this week touted a case study of the 1st implantation of its spinal scaffold, a bioresorbable device designed to help treat traumatic spinal cord injuries. The study, published in Neurosurgery, the journal of the Congress of Neurological Surgeons, involved a 25-year-old man with an American Spinal Injury Assn. Grade […]